
Molecule: INCLISIRAN
ChEMBL ID: CHEMBL3990033
Mechanism of Action: RNAI INHIBITOR
Max Phase: 3.0
Molecule Type: Oligonucleotide

Molecule: INCLISIRAN SODIUM
ChEMBL ID: CHEMBL5095052
Mechanism of Action: RNAI INHIBITOR
Max Phase: 4.0
Molecule Type: Oligonucleotide
First Approval: 2020

Molecule: ALIROCUMAB
ChEMBL ID: CHEMBL2109540
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2015

Molecule: EVOLOCUMAB
ChEMBL ID: CHEMBL2364655
Mechanism of Action: INHIBITOR
Max Phase: 4.0
Molecule Type: Antibody
First Approval: 2015

Molecule: BOCOCIZUMAB
ChEMBL ID: CHEMBL3137349
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: RG-7652
ChEMBL ID: CHEMBL2109539
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: RALPANCIZUMAB
ChEMBL ID: CHEMBL3137352
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: FROVOCIMAB
ChEMBL ID: CHEMBL4298016
Mechanism of Action: INHIBITOR
Max Phase: 2.0
Molecule Type: Antibody

Molecule: TAFOLECIMAB
ChEMBL ID: CHEMBL4594554
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: ONGERICIMAB
ChEMBL ID: CHEMBL4594566
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Antibody

Molecule: LERODALCIBEP
ChEMBL ID: CHEMBL4650405
Mechanism of Action: INHIBITOR
Max Phase: 3.0
Molecule Type: Protein
